Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Kitron Earnings Release 2020

Feb 11, 2021

3643_rns_2021-02-11_e8d3a662-45da-444d-ae4f-61b07e4ef325.pdf

Earnings Release

Open in viewer

Opens in your device viewer

Full year and Q4 results 2020

1

Peter Nilsson, CEO Cathrin Nylander, CFO 2021-02-11

Strong finish to an exceptional year

NOK Million Q4 2020 vs Q4 2019
Revenue
991.6
11.6 %
EBIT
75.7
39.6 %
Order Backlog
2 005.5
6.5 %
Operating cash flow
132.2
36.0 %
Net working capital
1 063.1
12.9 %
NOK Million 2020 vs 2019
Revenue
3 963.9
20.1 %
EBIT
312.6
55.1 %
Order Backlog
2 005.5
6.5 %
Operating cash flow
237.0
21.4 %
Net working capital
1 063.1
12.9 %

Highlights and important events

  • Revenue growth 12 % in Q4: Strong growth in Industry. Medical devices volumes normalized.
  • EBIT margin 7.6% (6.1%): Strong over all performance in Q4
  • EPS NOK 0.26 (0.19) +36% Full year 2020 EPS: 1.19 (0.74) +61%
  • Order backlog growth 6%: strong growth in Industry and Energy/Telecoms
  • Working capital: improved capital efficiency
  • Proposed dividend NOK 0.70 per share, to be paid in equal tranches in May and October
  • Capital Markets Day 17 March ( webcast)

Important agreements in the fourth quarter Major new orders:

KONGSBERG awarded orders to Kitron

  • In November, Kitron received order from 20 million from Kongsberg Defence & Aerospace AS with a value of over MNOK 20.
  • Production of RL542A, a core component in the new Flexible High Capacity Radio Link (FHCL), supplied by Kongsberg for the Norwegian Armed Forces.
  • Deliveries will start in 2021 and continue into 2022.
  • Production will take place at Kitron's plant in Arendal, Norway

Nortrop Grumman awarded development contract to Kitron

  • In November, Kitron was awarded awarded a development contract to update a F-35 test program set (TPS) and provide a repair capability for Kitron and a United States Government (USG) Depot.
  • The contract is for a three-year development program, with a total value of NOK 20 million.
  • The development will be done at Kitron's plant in Norway.

Financials

Industry sector shows strong growth

Q4 2020 vs Q4 2019 Share of total revenue
Industry
488.5

52.9 %
49.3 %
Defence/Aerospace
234.0

-7.0 %
23.6 %
Medical devices
172.8

-4.3 %
17.4 %
Energy/Telecoms
-8.5 %
7.8 %
77.6
Offshore/Marine

-64.2 %
1.9 %
18.8

Before group entities and eliminations

Outstanding full year results

  • Q4 EBIT strong improvement compared to last year
  • EBIT driven by over all strong performance,
  • Economies of scale and exceptional utilization of overhead Q2/Q3

Q4 EBIT by country: Improved profits and profitability

  • Norway and Sweden at strong margin levels and with improved profits
  • CEE (Lithuania and Poland) ended at solid profitability levels
  • Others (China and US) in total below strategic levels doe to weak 4Q.
Norway Sweden CEE Others
7.5 % 6.9 % 9.8 % 6.3 %
5.4 % 6.3 % 4.2 % 9.9 %

Balance sheet: Working capital efficiency improvement

  • Working capital ratios
  • o NOWC* 26.3% (26.3%)
  • o Cash conversion cycle* 98 (102)
  • o ROOC* 18.9% (14.8%)
    • exclusive IFRS16 ROOC% 21.3%

Cash flow

  • o Q4 Cash flow from operations MNOK 132 (97)
  • o YTD Cash flow from operations MNOK 237 (195)
  • Financial gearing
  • o NIBD/EBITDA 1.8 (2.8)
    • exclusive IFRS16 NIBD/EBITDA 1.6

Net working capital

Operating cash flow

Market development

Strong order backlog

  • Particularly strong growth in Industry and Energy/Telecom
Q4 2020 vs Q4 2019 Share of total revenue
Industry
629.1

28.5 %
31.4 %
Defence/Aerospace
768.8
-9.4 %
38.3 %
Medical devices 11.1 % 11.7 %
234.5
Energy/Telecoms 42.2 % 15.6 %
311.9
Offshore/Marine
61.1
-47.1 %
3.0 %

Outlook

Outlook

  • For 2021, Kitron expects revenue between NOK 3 900 and 4 200 million. EBIT margin is expected to be between 6.8 and 7.4 per cent.
  • The outlook for 2021 implies that Kitron is back on its long term trajectory for revenue and profitability after exceptional growth in 2020, largely driven by Corona-related demand within the Medical devices sector.
  • Growth is driven by Defence/Aerospace, Electrification and Connectivity within Energy/Telecom and Industry Sectors. Medical devices are expected to be normalised and in line with previous years.
  • The board emphasizes that every assessment of future conditions necessarily involves an element of uncertainty

Key takeaways

Summary Q4 2020

  • Outstanding full-year results
  • Kitron is back on its long term trajectory for revenue and profitability
  • Proposed dividend of NOK 0.70 per share
  • Capital Markets Day 17 March ( webcast)

Thank You!